Acorn Energy, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Andy Sassine. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Andy Sassine has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ARCT / Arcturus Therapeutics Holdings Inc. Chief Financial Officer, Director 221,764
US:ICAD / iCAD, Inc. Director 0
US:XCUR / Exicure, Inc. Director 50,000
US:GEMP / Gemphire Therapeutics Inc. Director 151,264
Chief Financial Officer, Director 475,192
US:MYAN / MYnd Analytics, Inc. 20,000
US:ACFN / Acorn Energy, Inc. Director 57,663
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Andy Sassine. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ACFN / Acorn Energy, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACFN / Acorn Energy, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2014-06-05 ACFN SASSINE ANDY 100 1.6600 6 26.5600 166 27 2.74 -150 -90.10
2014-06-05 ACFN SASSINE ANDY 2,300 1.6700 144 26.7200 3,841
2014-06-05 ACFN SASSINE ANDY 17,707 1.6800 1,107 26.8800 29,748
2014-06-05 ACFN SASSINE ANDY 500 1.6900 31 27.0400 845
2014-06-04 ACFN SASSINE ANDY 100 1.6200 6 25.9200 162
2014-06-04 ACFN SASSINE ANDY 3,500 1.6300 219 26.0800 5,705
2014-06-04 ACFN SASSINE ANDY 2,300 1.6400 144 26.2400 3,772
2014-06-04 ACFN SASSINE ANDY 1,200 1.6500 75 26.4000 1,980
2014-06-04 ACFN SASSINE ANDY 2,510 1.6700 157 26.7200 4,192
2014-06-04 ACFN SASSINE ANDY 3,653 1.6800 228 26.8800 6,137
2014-06-04 ACFN SASSINE ANDY 52,887 1.6900 3,305 27.0400 89,379
2014-06-04 ACFN SASSINE ANDY 54,627 1.7000 3,414 27.2000 92,866
2014-06-04 ACFN SASSINE ANDY 1,500 1.7100 94 27.3600 2,565
2014-06-04 ACFN SASSINE ANDY 1,730 1.7200 108 27.5200 2,976
2014-06-04 ACFN SASSINE ANDY 870 1.7300 54 27.6800 1,505
2014-06-04 ACFN SASSINE ANDY 500 1.7400 31 27.8400 870
2014-06-04 ACFN SASSINE ANDY 5,100 1.7600 319 28.1600 8,976
2014-06-04 ACFN SASSINE ANDY 3,300 1.7700 206 28.3200 5,841
2014-06-04 ACFN SASSINE ANDY 7,300 1.7800 456 28.4800 12,994
2014-06-04 ACFN SASSINE ANDY 14,480 1.7900 905 28.6400 25,919
2014-06-04 ACFN SASSINE ANDY 56,520 1.8000 3,532 28.8000 101,736
2013-12-02 ACFN SASSINE ANDY 12,224 3.5700 764 57.1200 43,640
2013-12-02 ACFN SASSINE ANDY 500 3.5760 31 57.2160 1,788
2013-11-27 ACFN SASSINE ANDY 3,600 3.6700 225 58.7200 13,212
2013-11-27 ACFN SASSINE ANDY 18,558 3.7400 1,160 59.8400 69,407
2013-10-18 ACFN SASSINE ANDY 6,988 3.2500 437 52.0000 22,711

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACFN / Acorn Energy, Inc. Insider Trades
Insider Sales ACFN / Acorn Energy, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACFN / Acorn Energy, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACFN / Acorn Energy, Inc. Insider Trades
Insider Purchases ARCT / Arcturus Therapeutics Holdings Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACFN / Acorn Energy, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-08-15 ARCT SASSINE ANDY 1,238 16.5580 1,238 16.5580 20,499 0 19.4800 3,618 17.65
2020-06-10 ARCT SASSINE ANDY 5,000 29.7400 5,000 29.7400 148,700
2019-12-05 ARCT SASSINE ANDY 5,649 9.7300 5,649 9.7300 54,965
2019-12-03 ARCT SASSINE ANDY 10,000 10.0000 10,000 10.0000 100,000
2019-08-23 ARCT SASSINE ANDY 10,000 10.9000 10,000 10.9000 109,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ARCT / Arcturus Therapeutics Holdings Inc. Insider Trades
Insider Sales ARCT / Arcturus Therapeutics Holdings Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACFN / Acorn Energy, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2024-06-12 ARCT SASSINE ANDY 50,000 32.0300 50,000 32.0300 1,601,500 300 8.9100 -1,156,000 -72.18

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ARCT / Arcturus Therapeutics Holdings Inc. Insider Trades
Insider Purchases MTVA / MetaVia Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACFN / Acorn Energy, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2017-03-10 GEMP SASSINE ANDY 21,119 9.4700 21,119 9.4700 199,997 325

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MTVA / MetaVia Inc. Insider Trades
Insider Sales MTVA / MetaVia Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACFN / Acorn Energy, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MTVA / MetaVia Inc. Insider Trades
Insider Purchases MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACFN / Acorn Energy, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Insider Trades
Insider Sales MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACFN / Acorn Energy, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Insider Trades
Insider Purchases XCUR / Exicure, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACFN / Acorn Energy, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XCUR / Exicure, Inc. Insider Trades
Insider Sales XCUR / Exicure, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACFN / Acorn Energy, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XCUR / Exicure, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Andy Sassine as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2025-08-20 2025-08-15 4/A ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		P - Purchase 1,238 221,764 0.56 16.56 20,499 3,671,968
2025-08-19 2025-08-15 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		P - Purchase -1,238 221,764 -0.56 16.56 -20,499 3,671,968
2025-07-17 2025-07-17 4 ICAD ICAD INC
Common Stock 		D - Sale to Issuer -1,198,382 0 -100.00
2024-06-14 2024-06-12 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		S - Sale -50,000 220,526 -18.48 32.03 -1,601,500 7,063,448
2023-08-17 2023-08-15 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		A - Award 1,223 270,526 0.45 17.37 21,248 4,700,119
2022-08-17 2022-08-15 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		A - Award 1,068 269,303 0.40 18.42 19,672 4,960,427
2022-02-09 2022-02-08 4 ICAD ICAD INC
Common Stock 		S - Sale -10,000 1,198,382 -0.83 5.49 -54,900 6,579,117
2022-02-09 2022-02-07 4 ICAD ICAD INC
Common Stock 		S - Sale -10,000 1,208,382 -0.82 5.26 -52,600 6,356,089
2022-01-11 2022-01-07 4 ICAD ICAD INC
Common Stock 		S - Sale -10,000 1,218,382 -0.81 6.07 -60,700 7,395,579
2022-01-11 2022-01-06 4 ICAD ICAD INC
Common Stock 		S - Sale -10,000 1,228,382 -0.81 6.20 -62,000 7,615,968
2022-01-04 2022-01-01 4 ICAD ICAD INC
Director Stock Option (right to buy) 		A - Award 30,000 30,000
2021-12-08 2021-12-07 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,238,382 -0.80 7.28 -72,800 9,015,421
2021-12-08 2021-12-06 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,248,382 -0.79 6.71 -67,100 8,376,643
2021-11-10 2021-11-09 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,258,382 -0.79 10.30 -103,000 12,961,335
2021-11-10 2021-11-08 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,268,382 -0.78 10.89 -108,900 13,812,680
2021-10-08 2021-10-07 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,278,382 -0.78 10.42 -104,200 13,320,740
2021-10-08 2021-10-06 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,288,382 -0.77 10.56 -105,600 13,605,314
2021-09-15 2021-09-14 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,298,382 -0.76 10.68 -106,800 13,866,720
2021-09-15 2021-09-13 4 ICAD ICAD INC
Common Stock 		S - Sale X -10,000 1,308,382 -0.76 11.09 -110,900 14,509,956
2021-06-04 2021-06-02 4 XCUR EXICURE, INC.
Stock Option (right to buy) 		A - Award 50,000 50,000
2021-03-08 3 XCUR EXICURE, INC.
Common Stock 		200,000
2021-03-08 2021-03-05 4 XCUR EXICURE, INC.
Stock Option (right to buy) 		A - Award 100,000 100,000
2021-02-17 2021-02-15 4 ICAD ICAD INC
Stock Option 		A - Award 30,000 30,000
2021-02-17 2021-02-15 4 ICAD ICAD INC
Common Stock 		A - Award 3,500 1,318,382 0.27
2021-01-05 2020-12-31 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 2,672 2,672
2020-12-22 2020-12-18 4 ARCT Arcturus Therapeutics Holdings Inc.
Stock Option (right to buy) 		A - Award 100,000 100,000
2020-10-01 2020-09-30 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 4,002 4,002
2020-09-09 2020-09-09 4 icad ICAD INC
Common Stock 		S - Sale X -10,000 1,314,882 -0.75 9.47 -94,746 12,457,981
2020-09-09 2020-09-08 4 icad ICAD INC
Common Stock 		S - Sale X -10,000 1,324,882 -0.75 9.40 -93,977 12,450,844
2020-08-10 2020-08-07 4 icad ICAD INC
Common Stock 		S - Sale X -10,000 1,334,882 -0.74 10.28 -102,821 13,725,390
2020-08-10 2020-08-06 4 icad ICAD INC
Common Stock 		S - Sale X -10,000 1,344,882 -0.74 10.31 -103,079 13,862,909
2020-07-15 2020-07-14 4 icad ICAD INC
Common Stock 		S - Sale X -10,000 1,354,882 -0.73 9.48 -94,754 12,838,049
2020-07-15 2020-07-13 4 icad ICAD INC
Common Stock 		S - Sale X -10,000 1,364,882 -0.73 9.53 -95,300 13,007,325
2020-07-01 2020-06-30 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 3,542 3,542
2020-06-10 2020-06-10 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		P - Purchase 5,000 273,245 1.86 29.74 148,700 8,126,306
2020-04-02 2020-04-01 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 5,448 5,448
2020-03-24 2020-03-20 4 icad ICAD INC
Convertible Debenture 		C - Conversion -40,000 0 -100.00
2020-03-24 2020-03-20 4 icad ICAD INC
Common Stock 		C - Conversion 2,015 1,374,882 0.15 7.51 15,133 10,325,364
2020-02-25 2020-02-21 4 icad ICAD INC
Convertible Debenture 		C - Conversion -40,000 0 -100.00
2020-02-25 2020-02-21 4 icad ICAD INC
Convertible Debenture 		C - Conversion -400,000 0 -100.00
2020-02-25 2020-02-21 4 icad ICAD INC
Common Stock 		C - Conversion 3,312 1,372,867 0.24 12.08 40,009 16,584,233
2020-02-25 2020-02-21 4 icad ICAD INC
Common Stock 		C - Conversion 100,000 1,369,555 7.88 4.00 400,000 5,478,220
2020-02-20 2020-02-18 4 ARCT Arcturus Therapeutics Holdings Inc.
Stock Option (right to buy) 		A - Award 80,000 80,000
2020-01-03 2020-01-01 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 30,000 30,000
2020-01-03 2019-12-31 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 5,577 5,577
2019-12-09 2019-12-05 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		P - Purchase 5,649 268,245 2.15 9.73 54,965 2,610,024
2019-12-05 2019-12-03 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		P - Purchase 10,000 257,596 4.04 10.00 100,000 2,575,960
2019-10-02 2019-09-30 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 5,458 5,458
2019-08-26 2019-08-23 4 ARCT Arcturus Therapeutics Holdings Inc.
Common Stock 		P - Purchase 10,000 247,596 4.21 10.90 109,000 2,698,796
2019-07-26 2019-07-24 4 GEMP Gemphire Therapeutics Inc.
Common Stock 		A - Award 15,000 151,264 11.01
2019-07-02 2019-06-28 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 5,512 5,512
2019-04-01 2019-03-29 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 6,584 6,584
2019-01-02 2019-01-01 4 icad ICAD INC
Director Stock Options (right to buy) 		A - Award 20,000 20,000
2019-01-02 2018-12-31 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 9,321 9,321
2019-01-02 3 ARCT Arcturus Therapeutics Ltd.
Ordinary Shares 		475,192
2019-01-02 3 ARCT Arcturus Therapeutics Ltd.
Ordinary Shares 		475,192
2019-01-02 3 ARCT Arcturus Therapeutics Ltd.
Ordinary Shares 		475,192
2018-12-27 2018-12-21 4 ICAD ICAD INC
Convertible Debenture 		A - Award 100,000 100,000 4.00 400,000 400,000
2018-10-02 2018-09-28 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 6,517 6,517
2018-07-02 2018-06-29 4 icad ICAD INC
Director Stock Option (right to buy) 		A - Award 6,219 6,219
2018-04-03 2018-03-30 4 icad ICAD INC
Common Stock 		A - Award 2,841 1,269,555 0.22 3.08 8,750 3,910,229
2018-02-16 2018-02-14 4 icad ICAD INC
Common Stock 		A - Award 4,000 1,266,714 0.32
2018-01-30 2018-01-29 4 GEMP Gemphire Therapeutics Inc.
Stock Option (right to buy) 		A - Award 10,800 10,800
2018-01-03 2017-12-29 4 icad ICAD INC
Common Stock (1) 		A - Award 2,544 1,262,714 0.20 3.44 8,751 4,343,736
2017-10-04 2017-09-29 4 icad ICAD INC
Common Stock 		A - Award 1,980 1,260,170 0.16 4.42 8,752 5,569,951
2017-07-05 2017-06-30 4 icad ICAD INC
Common Stock 		A - Award 2,088 1,258,190 0.17 4.19 8,749 5,271,816
2017-04-04 2017-03-31 4 ICAD ICAD INC
Common Stock 		A - Award 1,819 1,256,102 0.15 4.81 8,749 6,041,851
2017-03-14 2017-03-10 4 GEMP Gemphire Therapeutics Inc.
Warrant to Purchase Common Stock 		P - Purchase 15,840 15,840 9.47 150,005 150,005
2017-03-14 2017-03-10 4 GEMP Gemphire Therapeutics Inc.
Common Stock 		P - Purchase 21,119 136,264 18.34 9.47 199,997 1,290,420
2017-01-04 2017-01-03 4 ICAD ICAD INC
Common Stock 		A - Award 4,000 1,254,283 0.32 3.24 12,960 4,063,877
2017-01-04 2016-12-30 4 ICAD ICAD INC
Common Stock 		A - Award 2,701 1,250,283 0.22 3.24 8,751 4,050,917
2016-11-02 2016-11-01 4 MYAN MYnd Analytics, Inc.
Employee Stock Option (right to purchase) 		A - Award 20,000 20,000
2016-08-12 2016-08-10 4 GEMP Gemphire Therapeutics Inc.
Series A Convertible Preferred Stock 		C - Conversion -75,080 0 -100.00
2016-08-12 2016-08-10 4 GEMP Gemphire Therapeutics Inc.
8% Convertible Subordinated Promissory Notes 		C - Conversion 0
2016-08-12 2016-08-10 4 GEMP Gemphire Therapeutics Inc.
Common Stock 		C - Conversion 31,853 115,145 38.24 6.71 213,603 772,151
2016-08-12 2016-08-10 4 GEMP Gemphire Therapeutics Inc.
Common Stock 		J - Other 8,212 83,292 10.94 6.71 55,069 558,548
2016-08-12 2016-08-10 4 GEMP Gemphire Therapeutics Inc.
Common Stock 		C - Conversion 75,080 75,080
2016-08-08 2016-08-04 4 GEMP Gemphire Therapeutics Inc.
Stock Option (right to buy) 		A - Award 60,000 60,000
2016-04-07 2016-04-05 4 CNSO MYnd Analytics, Inc.
Common Stock 		A - Award 250,000 4,298,221 6.18
2016-01-06 2016-01-04 4 ICAD ICAD INC
Common Stock 		A - Award 4,000 1,247,582 0.32 5.16 20,640 6,437,523
2015-12-09 2015-12-07 4 ICAD ICAD INC
Option (right to buy) 		A - Award 5,358 5,358 4.01 21,486 21,486
2015-12-09 2015-12-07 4 ICAD ICAD INC
Common Stock 		A - Award 166 1,243,582 0.01 4.01 666 4,986,764
2015-12-09 3 ICAD ICAD INC
Common Stock 		2,486,832
2015-12-09 3 ICAD ICAD INC
Common Stock 		2,486,832
2015-08-24 2015-08-20 4 CNSO CNS RESPONSE, INC.
Option to Purchase 		A - Award 250,000 250,000
2014-09-24 2014-09-23 4 ACFN ACORN ENERGY, INC.
stock options 		A - Award 57,663 57,663
2014-06-06 2014-06-05 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 500 575,662 0.09 1.69 845 972,869
2014-06-06 2014-06-05 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 17,707 575,162 3.18 1.68 29,748 966,272
2014-06-06 2014-06-05 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 2,300 557,455 0.41 1.67 3,841 930,950
2014-06-06 2014-06-05 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 100 555,155 0.02 1.66 166 921,557
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 56,520 555,055 11.34 1.80 101,736 999,099
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 14,480 498,535 2.99 1.79 25,919 892,378
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 7,300 484,055 1.53 1.78 12,994 861,618
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 3,300 476,755 0.70 1.77 5,841 843,856
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 5,100 473,455 1.09 1.76 8,976 833,281
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 500 468,355 0.11 1.74 870 814,938
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 870 467,855 0.19 1.73 1,505 809,389
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 1,730 466,985 0.37 1.72 2,976 803,214
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 1,500 465,255 0.32 1.71 2,565 795,586
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 54,627 463,755 13.35 1.70 92,866 788,384
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 52,887 409,128 14.85 1.69 89,379 691,426
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 3,653 356,241 1.04 1.68 6,137 598,485
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 2,510 352,588 0.72 1.67 4,192 588,822
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 1,200 350,078 0.34 1.65 1,980 577,629
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 2,300 348,878 0.66 1.64 3,772 572,160
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 3,500 346,578 1.02 1.63 5,705 564,922
2014-06-06 2014-06-04 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 100 343,078 0.03 1.62 162 555,786
2014-01-03 2014-01-01 4 ACFN ACORN ENERGY, INC.
stock options 		A - Award 13,004 13,004
2013-12-04 2013-12-02 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 500 342,978 0.15 3.58 1,788 1,226,489
2013-12-04 2013-12-02 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 12,224 342,478 3.70 3.57 43,640 1,222,646
2013-12-02 2013-11-27 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 18,558 330,254 5.95 3.74 69,407 1,235,150
2013-12-02 2013-11-27 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 3,600 311,696 1.17 3.67 13,212 1,143,924
2013-10-18 2013-10-18 4 ACFN ACORN ENERGY, INC.
common stock 		P - Purchase 6,988 308,096 2.32 3.25 22,711 1,001,312
2013-09-23 3 ACFN ACORN ENERGY, INC.
Common Stock 		301,108
2013-09-23 2013-09-20 4 ACFN ACORN ENERGY, INC.
stock options 		A - Award 25,000 25,000
2013-08-14 2013-08-12 4 CNSO CNS RESPONSE, INC.
Convertible Note 		M - Exercise 0
2013-08-14 2013-08-12 4 CNSO CNS RESPONSE, INC.
Common Stock 		M - Exercise 3,498,200 4,048,221 636.01 0.25 874,550 1,012,055
2013-05-28 2013-05-23 4 CNSO CNS RESPONSE, INC.
Option to Purchase 		A - Award 250,000 250,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)